Comprehensive Evaluation of Traditional Herbal Medicine Combined With Adjuvant Chemotherapy on Post-Surgical Gastric Cancer: A Systematic Review and Meta-Analysis.

Authors:
Kim SD; Kim JH; Kim DH; Park JH; Gong Y and 3 more

Journal:
Integr Cancer Ther

Publication Year: 2024

DOI:
10.1177/15347354231226256

PMCID:
PMC10823854

PMID:
38281123

Journal Information

Journal Title: Integr Cancer Ther

Detailed journal information not available.

Publication Details

Subject Category: Integrative & Complementary Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article."

Evidence found in paper:

"Funding: The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HF20C0204 and HF23C0093)."

Evidence found in paper:

"The objective of this study is to conduct a meta-analysis to examine the effectiveness and safety of combining THM with adjuvant chemotherapy for the treatment of gastric cancer. The study was carried out in accordance with the guidelines of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). The study protocol has been registered on PROSPERO with the registration number CRD 42022354133. Conclusion:: THM may offer potential benefits as a complementary approach to post-surgical anticancer therapy in gastric cancer patients. Improved tumor response, quality of life, and survival rates were reported. However, it is important to exercise caution due to the possibility of publication bias, and further research is needed to confirm these findings.: Registration:PROSPERO CRD 42022354133"

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025